Market Growth The cell and gene therapy biomanufacturing market is witnessing unprecedented growth, driven by technological advancements, increased funding, and rising prevalence of chronic diseases. As of 2023, the market size was valued at USD 13.9 billion and is projected to reach USD 31.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.60% during the forecast period....